Public Release: 22-May-2012
Making microscopic machines using metallic glass

Oxford, May 22, 2012 - Researchers in Ireland have developed a new technology using materials called bulk metallic glasses to produce high-precision molds for making tiny plastic components. The components, with detailed microscopically patterned surfaces could be used in the next generation of computer memory devices and microscale testing kits and chemical reactors.

In their article published in the latest edition of the open access journal Materials Today, Michael Gilchrist, David Browne and colleagues at University College Dublin explain how bulk metallic glasses (BMGs) were discovered about thirty years ago. These materials are a type of metal alloy, but instead of having a regular, crystalline structure like an everyday metal such as iron or an alloy like bronze, the material's atoms are arranged haphazardly. This disordered, or amorphous atomic structure is similar to the amorphous structure of the silicon and oxygen atoms in the glass we use for windows and drinking vessels.

The haphazard arrangement of atoms in BMGs means that they have some very different mechanical properties from conventional metals. They can be heated and molded like plastics and they can be machined with microscopic precision below the grain size of conventional metals. BMGs also retain the strength and durability of normal metals.

Gilchrist and his colleagues have now exploited the haphazard nature of the atoms in BMGs to allow them to machine microscopic features on to the surface of a BMG. This is not possible with conventional metals such as tool steel used in molds which cannot typically be machined with better than 10 micrometer precision because of its crystalline grain structure. They have then used the resulting strong and durable metallic devices to carry out injection molding of plastic components with microscopic surface patterns using a straightforward tool production route.

"Our technology is a new process for mass producing high-value polymer components, on the micrometer and nanometer-scale," explains Gilchrist. "This is a process by which high-volume quantities of plastic components can be mass produced with one hundred times more precision, for costs that are at least ten times cheaper than currently possible."

The research team explains that with BMG injection molding equipment it is now possible to create millimeter-sized polymer components that have surface features of a similar size to mammalian cells at 10 micrometers or even the smallest viruses at less than 100 nanometers. The new manufacturing process could thus allow 'lab-on-a-chip' devices to be constructed that could handle and test samples containing single cells and viruses or large biomolecules including DNA and proteins.

Once the technology is extended to the tens of nanometers length scale, the team suggests that it could be used to make high-volume, low-cost, information storage systems. The team is currently optimizing their technology with this goal in mind.

The research team concludes, "The worldwide trend of miniaturization means that these devices and components are getting progressively smaller and smaller; the problem faced by today's technologies is that they will soon be unable to manufacture at these smaller dimensions at competitive prices. If you just consider the microfluidic devices market without the biological content: this is forecast to reach $5 billion by 2016."

###

Notes to editors

This article is "Towards nano injection molding" by Nan Zhang, Cormac J. Byrne, David J. Browne, and Michael D. Gilchrist. It appears in Materials Today, Volume 15, Issue 5, Page 216 (2012) published by Elsevier. Full text of the article is freely available from here. Journalists wishing to interview the authors may contact Dr. Stewart Bland at +44 1865 84 3124 or s.bland@elsevier.com

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.